Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Simvastatin Factorial Study in Primary Hypercholesterolemia
NCT00092651Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and simvastatin in hypercholesterolemia (10 arms), sponsored by Organon & Co. Primary endpoint: Low-Density Lipoprotein Cholesterol at 12 weeks. Started Sep 2002; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092651.